SMAD4 and cholangiocarcinoma: In 2006, Xu et al. described a murine model for CCA, which is based on the liver-specific deletion of both, Smad4 and Pten, by crossing mice carrying conditional Pten and Smad4 alleles with mice overexpressing a Cre recombinase controlled by an endogenous albumin promoter [64].